The power of early disease detection is unequivocally transformative, shifting the paradigm from reactive treatment to proactive intervention. For countless conditions, from aggressive cancers to insidious neurodegenerative disorders, identifying disease in its nascent stages dramatically improves prognosis, enhances treatment efficacy, and significantly reduces morbidity and mortality. Traditional diagnostic pathways, however, often face inherent limitations: the subtle nature of early symptoms, the subjective interpretation of clinical signs, the sheer volume
